| A Study of JNJ-1761981 in Participants With Solid Tumors (NCT07525141) | Johnson & Johnson Enterprise Innovation Inc. | 2026-05-18 |
| Adia Med of Winter Park LLC Chronic Kidney Disease Research Study (NCT07572890) | Adia Med of Winter Park LLC | 2026-05-18 |
| A Clinical Trial Evaluating the Monkeypox Recombinant Protein Vaccine (NCT07495202) | Shanghai JunTop Biosciences Co., LTD | 2026-05-18 |
| A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis (NCT07693738) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2026-05-18 |
| A Study to Compare the Pharmacokinetics and Safety of the ATB-U101 and ATB-U1011+ATB-U1012 and ATB-1011+ATB-1012 in Healthy Caucasian Participants (NCT07590466) | Autotelicbio | 2026-05-18 |
| Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS) (NCT07407582) | University of Arizona | 2026-05-18 |
| A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult (NCT07632573) | Benethera (Shaoxing) Biotechnology Co., Ltd. | 2026-05-18 |
| A Study to Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of Multiple Doses of Oral Povorcitinib or Topical Ruxolitinib Cream in Healthy Adult Participants (NCT07588139) | Incyte Corporation | 2026-05-18 |
| Hormones, Outcomes, and Pain Pathways in Exercise Study (NCT07579182) | University of Houston | 2026-05-17 |
| Trial of JYB1904 Injection in Adolescent Participants (NCT07513857) | Jemincare | 2026-05-17 |
| The Impact of Light Exposure on Cognitive Function in Classrooms (NCT06325150) | Michigan State University | 2026-05-16 |
| Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia (NCT07397325) | Applied Biology, Inc. | 2026-05-16 |
| A Study of HS-20136-2 in Healthy Participants (NCT07483437) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2026-05-15 |
| Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhabdoid Tumor (NCT07331064) | Sarah Rumler | 2026-05-15 |
| PrP-targeting siRNA Safety & Mechanism Study (NCT07444580) | Broad Institute of MIT and Harvard | 2026-05-15 |
| Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers (NCT07529951) | Eilean Therapeutics | 2026-05-15 |
| Bioequivalence Study of Liquid Metformin (100 and 250 mg/mL) vs IR Tablets (NCT07300033) | Aspargo Labs, Inc | 2026-05-15 |
| A Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination Therapy in Subjects With HR-Positive/HER2-Negative Cancer (NCT07358377) | Atridia Pty Ltd. | 2026-05-15 |
| Snacks and Brain Health (NCT07348406) | Texas Tech University Health Sciences Center | 2026-05-15 |
| Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib (NCT07486648) | Shanxi Province Cancer Hospital | 2026-05-15 |
| aKLmRNA-mediated Protein Replacement Therapy (NCT07544420) | Klothea Bio Inc | 2026-05-15 |
| Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial (NCT07382726) | M.D. Anderson Cancer Center | 2026-05-15 |
| Treatment of Truncated ALK-positive Bone Cancer Using Crizotinib (Xalkori) or Alectinib (Alecensa) (NCT07560410) | China Medical University Hospital | 2026-05-15 |
| A Pharmacokinetic Study of HDM1005 Injection in Participants With Impaired Renal Function and Healthy Participants (NCT07559240) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2026-05-15 |
| Study of IBI3016 in People With Mild or Moderate Hypertension Patients (NCT07556796) | Innovent Biologics (Suzhou) Co. Ltd. | 2026-05-15 |
| A Single-Arm, Open-Label Phase Ia/Ib Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of FS-207 in Patients With Advanced Solid Tumors With High Microsatellite Instability (MSI-H) (NCT07593144) | Foresight Therapeutics (Hefei) Co., Ltd. | 2026-05-15 |
| A Study of GSK4771261 in Healthy Participants Aged 25 to 55 Years of Age Inclusive (NCT07600450) | GlaxoSmithKline | 2026-05-15 |
| Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors (NCT07558200) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2026-05-15 |
| Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma (NCT06670976) | Roswell Park Cancer Institute | 2026-05-15 |
| Clinical Study of CVL006 Combination With 9MW2821 (NCT07615660) | Convalife (Shanghai) Co., Ltd. | 2026-05-15 |
| A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease (NCT07543861) | University of Michigan | 2026-05-15 |
| Yoga for Black and Brown Women Who Have Experienced Abuse From an Intimate Partner (NCT07546266) | The University of Akron | 2026-05-15 |
| Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma (NCT05976555) | Medical College of Wisconsin | 2026-05-15 |
| A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I (NCT07554924) | Lanyue Biotech (Hangzhou) Co., Ltd. | 2026-05-15 |
| SIM0613 in Participants With Advanced Solid Tumors (NCT07618260) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2026-05-15 |
| A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months of Age Receiving a Single Booster Dose (NCT07406334) | GlaxoSmithKline | 2026-05-15 |
| A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease (NCT07599670) | AbbVie | 2026-05-15 |
| A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS) (NCT07571200) | Eli Lilly and Company | 2026-05-14 |
| A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis (NCT07571174) | Eli Lilly and Company | 2026-05-14 |
| A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants (NCT07525544) | ViiV Healthcare | 2026-05-14 |
| CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia (NCT07464951) | Stephan Grupp MD PhD | 2026-05-14 |
| Ceftriaxone for Post-Treatment Lyme Disease (NCT06785402) | Hackensack Meridian Health | 2026-05-14 |
| A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated (NCT07553429) | Boehringer Ingelheim | 2026-05-14 |
| Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older. (NCT07582796) | Ab&B Bio-tech Co., Ltd.JS | 2026-05-14 |
| PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC (NCT07630363) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-05-14 |
| A Study to Evaluate the Safety, PK, and Immunogenicity of Recombinant Human Hyaluronidase in Healthy Subjects (NCT07484893) | Shanghai Henlius Biotech | 2026-05-14 |
| Sitagliptin With Pembro in RCC and Melanoma (NCT07634380) | Fernando Maciel Barbosa | 2026-05-14 |
| A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of VGN-R08b in Patients With Type III Gaucher's Disease (NCT07603050) | Shanghai Vitalgen BioPharma Co., Ltd. | 2026-05-14 |
| Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor (NCT07171203) | University of California, San Diego | 2026-05-13 |
| A Trial to Assess Safety, Tolerability, and Pharmacokinetics of AN01 Inhalation Powder in Healthy Participants (NCT07554365) | AirNexis Therapeutics, Inc. | 2026-05-13 |
| A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Solid Tumors (NCT07591155) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-05-13 |
| A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in People With Reduced Liver Function and Normal Liver Function (NCT07587710) | Novo Nordisk A/S | 2026-05-13 |
| Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study (NCT07708714) | Children's Hospital Medical Center, Cincinnati | 2026-05-13 |
| A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies (NCT07572006) | Janssen Research & Development, LLC | 2026-05-13 |
| A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults (NCT07597928) | Pfizer | 2026-05-13 |
| Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer (NCT07318324) | M.D. Anderson Cancer Center | 2026-05-13 |
| Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer (NCT06930755) | Nerviano Medical Sciences | 2026-05-13 |
| TSPO Endothelial - EMPATHY (NCT07697183) | Imperial College London | 2026-05-13 |
| Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas (NCT06465199) | Milton S. Hershey Medical Center | 2026-05-13 |
| Elacestrant in Advanced Triple Positive Breast Cancer (NCT07612215) | NYU Langone Health | 2026-05-13 |
| Study to Assess Adverse Events and How Oral Emraclidine Moves Through the Body of Adult Healthy Volunteers (NCT07587008) | AbbVie | 2026-05-12 |
| Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells (NCT07220993) | Baylor College of Medicine | 2026-05-12 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease (NCT07354724) | Denali Therapeutics Inc. | 2026-05-12 |
| A Study of NHL907 in Healthy Adult Participants (NCT07580924) | NeuHyll AUS Pty Ltd | 2026-05-12 |
| A Pharmacokinetic Study of Gecacitinib Hydrochloride Tablets in Healthy Adult Participants. (NCT07565597) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2026-05-12 |
| Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain (NCT07117032) | Case Comprehensive Cancer Center | 2026-05-12 |
| A Study of SYS6051 in Subjects With Advanced Solid Tumors (NCT07591285) | CSPC Megalith Biopharmaceutical Co.,Ltd. | 2026-05-12 |
| A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease (NCT07536061) | Sarepta Therapeutics, Inc. | 2026-05-12 |
| A Study of Ivonescimab in People With Non-Small Cell Lung Cancer (NCT07594522) | Memorial Sloan Kettering Cancer Center | 2026-05-12 |
| A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fasting Conditions (NCT07587697) | Pfizer | 2026-05-11 |
| QLS5212 for Participants With Advanced Solid Tumors (NCT07467629) | Qilu Pharmaceutical Co., Ltd. | 2026-05-11 |
| SGLT2i, Pioglitazone, and Ketone Production in T2D (NCT07053319) | The University of Texas Health Science Center at San Antonio | 2026-05-11 |
| MTOR Inhibitors in Older Adults (NCT06727305) | University of Texas Southwestern Medical Center | 2026-05-11 |
| Evaluate Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 After Single Subcutaneous Injection in Healthy Chinese Volunteers (NCT07535775) | SPH-BIOCAD (HK) Limited | 2026-05-11 |
| A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets (NCT07652047) | Corxel Pharmaceuticals | 2026-05-11 |
| A Study of TAK-505 in Adults With Solid Tumors (NCT07436728) | Takeda | 2026-05-11 |
| Study of INCA036978 in Participants With Myeloproliferative Neoplasms (NCT07441694) | Incyte Corporation | 2026-05-11 |
| A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder (NCT07540338) | Alzamend Neuro, Inc. | 2026-05-11 |
| Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy (NCT07516288) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-05-11 |
| Universal STAR-T Cell Injection in R/R Autoimmune Diseases. (NCT07599280) | Jian Zhu | 2026-05-11 |
| Behavioral Economic Attributes of Recreation (NCT07282418) | Rush University Medical Center | 2026-05-11 |
| A Clinical Trial of MK-4646 With Bictegravir/Emtricitabine/Tenofovir Alafenamide and Dolutegravir in Healthy Adult Participants (MK-4646) (NCT07532304) | Merck Sharp & Dohme LLC | 2026-05-11 |
| Study of Food Effects of VV913 Capsules in Chinese Healthy Volunteers (NCT07565792) | Vigonvita Life Sciences | 2026-05-11 |
| A Drug-Drug Interaction Study of Itraconazole and Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-017) (NCT07548606) | Merck Sharp & Dohme LLC | 2026-05-11 |
| Drug-Drug Interactions of JMKX003142 in Healthy Participants (NCT07565441) | Jemincare | 2026-05-11 |
| Intratumoral Macrophage Exosomes With Mechanobiological Reprogramming for Advanced Solid Tumors (NCT07563972) | West China Hospital | 2026-05-10 |
| Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC (NCT07565740) | West China Hospital | 2026-05-10 |
| A Phase I Clinical Trial to Evaluate the Pharmacokinetic Characteristics of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Moderate Renal Impairment and Normal Renal Function (NCT07694869) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2026-05-10 |
| Eque-cel for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma (NCT07510100) | Nanjing IASO Biotechnology Co., Ltd. | 2026-05-10 |
| TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis (NCT06726577) | Talengen Institute of Life Sciences, Shenzhen, P.R. China. | 2026-05-10 |
| Safety and Efficacy of JMKX000189 for Chemotherapy-Induced Peripheral Neuropathy (NCT07601386) | Shanghai Jeyou Pharmaceutical Co., Ltd. | 2026-05-10 |
| Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of L03TD1 in Healthy Volunteers (NCT07533539) | Celltrion | 2026-05-09 |
| Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function (NCT07551570) | Jiangsu vcare pharmaceutical technology co., LTD | 2026-05-09 |
| A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health (NCT07565090) | International AIDS Vaccine Initiative | 2026-05-08 |
| A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is Tolerated in the Body of Healthy Adults. (NCT07575906) | Pfizer | 2026-05-08 |
| Dasatinib for HIV-1 Reservoir Reduction (NCT07342491) | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-05-08 |
| Relative Bioavailability Study of HNC364 Injectable Suspension (NCT06798519) | Guangzhou Henovcom Bioscience Co. Ltd. | 2026-05-08 |
| A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults (NCT07594769) | Pfizer | 2026-05-08 |
| Adapt NK for High Risk Myeloid Diseases as Bridge to Allo HSCT (NCT07591649) | Masonic Cancer Center, University of Minnesota | 2026-05-08 |
| A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant (NCT07020533) | City of Hope Medical Center | 2026-05-08 |